Remove merck-astellas-pfizer-bring-down-house-keytruda-padcev-fda-nod-bladder-cancer
article thumbnail

Merck, Astellas and Pfizer bring down the house with Keytruda-Padcev FDA nod in bladder cancer

Fierce Pharma

The FDA has signed off on Astellas and Pfizer’s Padcev in combination with Merck’s Keytruda as a first-line treatment for bladder cancer.

FDA 188